|
MCM8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66677782686975E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.09390274616317E-11 |
| Normal-vs-Stage2 |
4.18069999730264E-08 |
| Normal-vs-Stage3 |
1.16840004338314E-09 |
| Normal-vs-Stage4 |
1.89990000398765E-08 |
| Stage1-vs-Stage2 |
4.336600E-01 |
| Stage1-vs-Stage3 |
4.758400E-01 |
| Stage1-vs-Stage4 |
2.569200E-01 |
| Stage2-vs-Stage3 |
8.312600E-01 |
| Stage2-vs-Stage4 |
7.819400E-01 |
| Stage3-vs-Stage4 |
6.098600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25010010623805E-11 |
| Normal-vs-AfricanAmerican |
1.02190000017544E-07 |
| Normal-vs-Asian |
8.12970000207969E-08 |
| Caucasian-vs-AfricanAmerican |
2.182600E-01 |
| Caucasian-vs-Asian |
3.578400E-01 |
| AfricanAmerican-vs-Asian |
6.141000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.47350037621652E-10 |
| Normal-vs-Female |
4.95614660422916E-12 |
| Male-vs-Female |
1.295190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.16420231630354E-11 |
| Normal-vs-Age(41-60Yrs) |
2.27760033055802E-11 |
| Normal-vs-Age(61-80Yrs) |
1.67070002277114E-09 |
| Normal-vs-Age(81-100Yrs) |
9.904900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.300400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.705800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.678800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.101600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.185200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.469200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.260200E-01 |
| Classical-VS-Follicular |
3.588100E-02 |
| Classical-VS-Other |
1.514790E-01 |
| Classical-VS-Normal |
7.61249999703395E-08 |
| Tall-VS-Follicular |
3.284200E-01 |
| Tall-VS-Other |
2.411600E-01 |
| Tall-VS-Normal |
3.67390000000078E-05 |
| Follicular-VS-Other |
6.578200E-01 |
| Follicular-VS-Normal |
1.55390000866618E-09 |
| Other-VS-Normal |
1.183790E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.60094160150948E-13 |
| Normal-vs-N1 |
8.88020001976741E-09 |
| N0-vs-N1 |
7.009000E-01 |
|
|
